-disastrous Q, no way around it. top ideas down 24-54%.
-a mix of timing, and betting too much on short-term catalysts that didn't pan out (including losing 100% on some qure options)
-I do expect huge turn arounds, as I'm still holding my top pos
1
1
170
JCY retweeted
Implied consideration paid per $TNR.v per share of approximately $0.48, which is comprised of approximately $0.38 per TNR Share payable in Altius $ALS.TO common shares and approximately $0.10 per TNR share payable in TNR SpinCo shares
Altius Minerals Announces Definitive Agreement to Acquire TNR Gold $ALS.TO tinyurl.com/282vbz9c
$dbo.to 2027Q2 earnings notes
OUCH
-low new screen installs. Seasonality, not a problem
-royalty being up only 14% while BO is blowing up the roof and not having a good explanation for the disparency. Uncertainty, risk. Not good.
1
3
782
$dcth 2026Q3 earnings
-explosif quarter wow great numbers. Chopin and training back up teams probably contributed both
-increased 2026 rev guidance again to 115-117mil WITH taking into account seasonality from doctors taking vacations in Q4. 👍 Mgmt
1
3
692
Listen to the bagel man 🥯
Is an FDA AdCom for AMT-130 still taken to mean that approval is a coin-toss? No. Of 140 pivotal votes since Nov 2016, 95 were followed by approval (68%). Rare disease: 39 of 50 (78%). Cell and gene therapy: 10 of 11 (91%). Priority review: 56 of 70 (80%). AMT-130 is all three.
2
293
$qure 2026Q3 earning call notes
-confirmatory study will be recruiting from NA, EU, and LatAm. No Asia. After initial 36months of amt130 vs SoC, all SoC patients will be offered amt130 in a separate open label study.
2
13
1,254
-# of centers at approval: 15+ for sure, potentially 25-30. Example capacity range of 2/wk to 1/mo. Seems to talk about only US, only high capacity centers here.
Range of 180-2880 yr. Extremes impossible as centers have diff capacity
My guess = 700/yr ish
(3/mo*12mo*20centers)
1
6
140
Interesting move. Frees times and attention for the dev of hub&spoke mines in the US. Paid in stock to keep exposure, while having flexibility to sell for cash as needed once 6months lock up is over
$moon.v $bmm
bluemoonmetals.com/blue-moon…
1
1
295
"The Parties will work together to distribute the Shares to the shareholders of Blue Moon within 12 months of closing of the Transaction."
@AdventusCEO am I reading that the plan is for ACG shares to be distributed to shareholders as opposed to held within BMM?
47
Y'all r crazy for $qure being up <10% premarket on this. Just google approval rate for accepted BLA with PR and do the math
Added a bunch at 27$, oversize me
UniQure $QURE announces FDA acceptance and Priority Review of BLA for AMT-130 for treatment of Huntington's disease
PDUFA May 1, 2027
"In its acceptance letter, the FDA stated that they are tentatively planning to discuss this application at an Advisory Committee meeting. The Company will be notified once the date and timelines have been finalized."
JCY retweeted
$qure $clpt
You telling me this is meaningless???
“INOVIO filed its BLA under the accelerated approval pathway. In the file acceptance letter, the FDA noted as a potential review issue its preliminary conclusion that the company has not submitted adequate information to justify eligibility for the accelerated approval pathway.”
ir.inovio.com/news/news-deta…
JCY retweeted
We are at the juncture where the FDA is approving penny stock drugs. Godspeed and have a great weekend!
Oh and if they could cut down Berg permitting time by a year or 2 my port wouldn't say no 😅 $surg.v
99









